FGEU:F:F-Fidelity UCITS ICAV - Fidelity Global Quality Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 7.041

Change

-0.43 (-5.76)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-23.14 (-4.44%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-2.49 (-5.24%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-2.60 (-4.98%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.75 (-5.30%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-10.10 (-4.76%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.82%)

USD 41.48B
0ZC:F Zscaler Inc

-12.68 (-7.25%)

USD 37.92B
BSND:F Danone SA

+0.50 (+3.60%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing FGEU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.84% 29% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.84% 28% F 42% F
Trailing 12 Months  
Capital Gain -6.56% 25% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.56% 23% F 42% F
Trailing 5 Years  
Capital Gain 57.45% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.45% 54% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 9.10% 65% D 63% D
Dividend Return 9.10% 62% D 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.03% 52% F 85% B
Risk Adjusted Return 69.87% 69% C- 77% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike